Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE : revenue, balance sheet and financial ratios

SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE is a French company founded 8 years ago, specialized in the sector Activités des sociétés holding. Based in BOULOGNE-BILLANCOURT (92100), this company of category PME shows in 2025 a net income positive of 451 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE (SIREN 833839756)
Indicator 2025 2022
Revenue N/C N/C
Net income 451 174 € 200 234 €
EBITDA -60 017 € -3 233 €
Net margin N/C N/C

Revenue and income statement

In 2025, SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE generates positive net income of 451 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2025: 200 k€ -> 451 k€.

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-60 017 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-60 017 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

451 174 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 7%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 93%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.2 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

7.187%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

93.243%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.231

Solvency indicators evolution
SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE

Sector positioning

Debt ratio
7.19 2025
2022
2025
Q1: 0.04
Med: 8.09
Q3: 54.01
Good +21 pts over 2 years

In 2025, the debt ratio of SPFPLARL DE PHARMACIENS D... (7.19) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
93.24% 2025
2022
2025
Q1: 21.27%
Med: 67.32%
Q3: 92.99%
Excellent

In 2025, the financial autonomy of SPFPLARL DE PHARMACIENS D... (93.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.23 years 2025
2022
2025
Q1: 0.0 years
Med: 0.19 years
Q3: 2.98 years
Average +10 pts over 2 years

In 2025, the repayment capacity of SPFPLARL DE PHARMACIENS D... (0.23) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 930.56. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

930.556

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-1.755

Liquidity indicators evolution
SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE

Sector positioning

Liquidity ratio
930.56 2025
2022
2025
Q1: 161.8
Med: 834.57
Q3: 4761.54
Good

In 2025, the liquidity ratio of SPFPLARL DE PHARMACIENS D... (930.56) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-1.75x 2025
2022
2025
Q1: -62.1x
Med: 0.0x
Q3: 0.0x
Average

In 2025, the interest coverage of SPFPLARL DE PHARMACIENS D... (-1.8x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 28 days. Favorable situation: supplier credit is longer than customer credit by 28 days.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

28 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE

Positioning of SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE in its sector

Comparison with sector Activités des sociétés holding

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (20 transactions). This range of 179 918€ to 5 544 599€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2025
Indicative
179k€ 926k€ 5544k€
926 633 € Range: 179 918€ - 5 544 599€
NAF 5 année 2025

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 20 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des sociétés holding)

Compare SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des sociétés holding

Frequently asked questions about SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE

What is the revenue of SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE ?

The revenue of SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE profitable?

Yes, SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE generated a net profit of 451 k€ in 2025.

Where is the headquarters of SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE ?

The headquarters of SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE is located in BOULOGNE-BILLANCOURT (92100), in the department Hauts-de-Seine.

Where to find the tax return of SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE ?

The tax return of SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE operate?

SPFPLARL DE PHARMACIENS D'OFFICINE KOPLE operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.